| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 07/13/2005 | EP1551804A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/13/2005 | EP1551798A1 Novel sulphones for inhibition of gamma secretase |
| 07/13/2005 | EP1551797A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 07/13/2005 | EP1551795A1 Inhibitors of histone deacetylase |
| 07/13/2005 | EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors |
| 07/13/2005 | CN1639147A Synthesis of 4, 5-dihydro-pyrazolo [3, 4-c] pyrid-2-ones |
| 07/13/2005 | CN1639142A Method for producing 3-amidinophenylalanine derivatives |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639124A Aminotetralin derivatives as muscarinic receptor antagonists |
| 07/13/2005 | CN1639123A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1636993A Process for producing novel form of paroxetine hydrochloride anhydrate |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636980A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 07/13/2005 | CN1636979A Method for separating cis-3, 5-dimethylpiperidine from a mixture of its geometrical isomers |
| 07/13/2005 | CN1636976A Mutilin derivatives and their use as antibacterials |
| 07/13/2005 | CN1636565A Modified form of the r(-)-n-(4, 4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210262C Method for preparing methylsulfonate trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperid-1-yl)-1-propanol |
| 07/13/2005 | CN1210261C Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5HT1A receptor activity |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916929 Via hydrolysis of 1-benzyl-4-cyano-4-phenylpiperidine in acidic medium; for tachykinin antagonist drugs |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916833 Substituted piperidines |
| 07/12/2005 | US6916830 Substituted tetrahydroisoquinolines as C5a receptor modulators |
| 07/12/2005 | US6916829 Method for enhancing mutant enzyme activity in gaucher disease |
| 07/12/2005 | US6916822 For preventive and/or therapeutic treatment of nerve system diseases including schizophrenia, depression, cerebral apoplexy, epilepsy, Alzheimer's disease, and Parkinson's disease |
| 07/12/2005 | US6916817 Inhibitors of metalloproteinases |
| 07/12/2005 | CA2137525C Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate |
| 07/09/2005 | CA2455018A1 Process for the preparation of piperidine derivatives |
| 07/07/2005 | WO2005061483A2 Modulators of peripheral 5-ht receptors |
| 07/07/2005 | WO2005061470A1 1-akan-2-ol substituted piperazine and piperidine compounds |
| 07/07/2005 | WO2005061457A1 Organic compounds |
| 07/07/2005 | WO2005061453A1 Antharquinone compounds as anti cancer compounds |
| 07/07/2005 | WO2005061442A1 Opioid receptor antagonists |
| 07/07/2005 | WO2005060947A2 Agonist and antagonist ligands of the nociceptin receptor |
| 07/07/2005 | WO2005060603A2 Nitric oxide releasing pyruvate compounds, compositions and methods of use |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005042521A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 07/07/2005 | WO2005037782A3 Derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/07/2005 | US20050148637 Neurotrophic low molecular weight ketones and tioester compounds for treatment of nervous system disorders and neurodegenerative conditions |
| 07/07/2005 | US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment |
| 07/07/2005 | US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/07/2005 | US20050148595 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 07/07/2005 | US20050148583 1-[2-[2-(4-Diethylcarbamoylbenzyl)phenoxy]ethyl]-4-(1,3-dihydro-2H-benzimidazol-2-on-1-yl)piperidine; agonist, antagonist, partial or inverse agonist; schizophrenia, depression, cerebral apoplexy, epilepsy, Alzheimer's disease, and Parkinson's disease; analgesic; pharmacokinetics |
| 07/07/2005 | US20050146263 Liquid crystalline emitter and charge-transport materials for use in organic light emitting devices (OLED); photopolymerization; high luminous output; tetra-enes based on a fluorene ring skeleton and having at least one heterocyclic ring attached |
| 07/07/2005 | DE10358539A1 Carbonsäureamidderivate Carboxamide |
| 07/07/2005 | CA2550839A1 Antharquinone compounds as anti cancer compounds |
| 07/07/2005 | CA2550257A1 1-akan-2-ol substituted piperazine and piperidine compounds |
| 07/07/2005 | CA2549412A1 Nitric oxide releasing pyruvate compounds, compositions and methods of use |
| 07/07/2005 | CA2549009A1 Opioid receptor antagonists |
| 07/06/2005 | EP1549617A1 Organic acid salt of amlodipine |
| 07/06/2005 | EP1549616A1 Organic acid salt of amlodipine |
| 07/06/2005 | EP1549615A1 Naphthamide derivatives and their use |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP0776327B1 New multimerizing agents |
| 07/06/2005 | CN1634887A Process for chiral synthesis of (2S, 6R)-2, 6-dialkyl piperidine hydrochloride |
| 07/06/2005 | CN1209351C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR3 receptor antagonists |
| 07/05/2005 | US6914142 Antiinflammatory agents; rheumatic diseases |
| 07/05/2005 | US6914079 Antiproliferative agents; anticancer agents |
| 07/05/2005 | US6913674 Process for fractionating water-containing crude amine mixtures from amine synthesis |
| 07/05/2005 | CA2309485C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2165446C Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 07/05/2005 | CA2119572C Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs |
| 07/05/2005 | CA2064382C Pharmaceutical compounds |
| 06/30/2005 | WO2005059037A1 Reagent for detecting an analyte |
| 06/30/2005 | WO2005058972A1 Process for the oxidation of hydroxy compounds by means of nitroxy compounds |
| 06/30/2005 | WO2005058885A2 Piperidine derivatives and their use as glycine transporter inhibitors |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058826A1 New 5,6-dihydropyrin-2-one compounds useful as inhibitors of thrombin |
| 06/30/2005 | WO2005058825A1 Amlodipine gentisate and a method of its preparation |
| 06/30/2005 | WO2005058824A2 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprote in b |
| 06/30/2005 | WO2005058822A1 Substituted amino-cycloalkanes |
| 06/30/2005 | WO2005058818A1 Process for the recovery of nitroxy compounds from organic solutions and oxidation process |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2004100960A8 Anti-inflammatory phosphonate compounds |
| 06/30/2005 | WO2004096236A3 Immunomodulator phosphonate conjugates |
| 06/30/2005 | WO2004089926A3 Genipin derivatives and uses thereof |
| 06/30/2005 | WO2004055006A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143539 Polymerizable composition with free radicals and by controlling polymerization |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143419 Guanidine and amidine derivatives as factor Xa inhibitors |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | CA2550012A1 Urea derivative, process for producing the same and use |
| 06/30/2005 | CA2549741A1 Reagent for detecting an analyte |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2548793A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | CA2547064A1 New 5,6-dihydropyrin-2-one compounds useful as inhibitors of thrombin |